These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics. Moncada Lorenzo E; Garcia RV; Barberia Layana JJ; Morant Ciscard JA; Calleja Canelas A Curr Ther Res Clin Exp; 1977 Jan; 21(1):50-7. PubMed ID: 401712 [No Abstract] [Full Text] [Related]
5. [Retrolective study design -- a new tool of evidence-based medicine]. Martin S Dtsch Med Wochenschr; 2005 Jul; 130 Suppl 2():S86-90. PubMed ID: 15988675 [No Abstract] [Full Text] [Related]
6. Oral hypoglycemic agents and the pregnant diabetic: "from bench to bedside". Langer O Semin Perinatol; 2002 Jun; 26(3):215-24. PubMed ID: 12099312 [TBL] [Abstract][Full Text] [Related]
8. Use oral hypoglycemics with caution.. Jackson JE; Bressler R Geriatrics; 1988 Aug; 43(8):77-83. PubMed ID: 3136057 [No Abstract] [Full Text] [Related]
9. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide). Loubatiéres A; Mariani MM; Ribes G; Alric R Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675 [No Abstract] [Full Text] [Related]
10. [40 years of using sulfonylurea derivatives for treatment of diabetes]. Sieradzki J Przegl Lek; 1996; 53(9):641-6. PubMed ID: 8992529 [TBL] [Abstract][Full Text] [Related]
12. [Molecular basis of oral hypoglycemic sulfonylurea action]. Owecki M; Horst-Sikorska W; Sowiński J Pol Merkur Lekarski; 2003 Nov; 15(89):445-8. PubMed ID: 14969140 [TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of gliquidone--short acting sulfonylurea derivative--comparison with glibenclamide and gliclazide]. Rupprecht E; König E; Limmer J Pol Tyg Lek; 1993 Apr; 48 Suppl 1():31-2. PubMed ID: 8516203 [No Abstract] [Full Text] [Related]
14. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus. Clark HE; Matthews DR Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981 [TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide. Artini D; Abbiati R; Orsini G; Parenti MA; Bloch K; Daturi S; Mandelli V Diabetologia; 1973 Sep; ():311-6. PubMed ID: 4204091 [No Abstract] [Full Text] [Related]
16. [Diamicron in the treatment of diabetes mellitus type 2]. Balabolkin MI; Morozova TP; Chachiashvili MV Sov Med; 1987; (7):21-2. PubMed ID: 3317910 [No Abstract] [Full Text] [Related]
17. The new oral antidiabetic drugs. Moss JM; Delawter DE Am Fam Physician; 1984 Nov; 30(5):119-21. PubMed ID: 6437197 [No Abstract] [Full Text] [Related]
18. Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients. Tseng CH; Huang TS Diabetes Res Clin Pract; 2005 Nov; 70(2):193-4. PubMed ID: 16188579 [No Abstract] [Full Text] [Related]
19. [Clinical evaluation of a new sulfonylurea derivative, preparation SPC-703, based on a 5-year observation]. Horoszek-Maziarz S; Berliński E; Jaromczyk-Slisz J; Rachoń K; Wójcikowski C; Słomiński M; Orłowska-Kunikowska E; Krupa-Wojciechowska B Pol Tyg Lek; 1985 May; 40(18):516-8. PubMed ID: 3892514 [No Abstract] [Full Text] [Related]